Rheumatology Doctors in Edinburg, TX Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Jorge C Zamora-quezada, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2601 Cornerstone Blvd, Edinburg, TX 78539 Phone: 956-664-1400    Fax: 956-664-1450

Dr. Emilia C. Dulgheru, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1506 S Lone Star Way Ste 3, Edinburg, TX 78539 Phone: 956-362-2400    Fax: 956-362-2404

Dr. Angela Christensen, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1506 S Lone Star Way Ste 3, Edinburg, TX 78539 Phone: 956-362-2400    Fax: 956-362-2404

Jorge A Ortegon, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2821 Michael Angelo Ste 300, Edinburg, TX 78539 Phone: 956-630-1225    Fax: 956-630-1841

Rogelio Eduardo Rojas, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5111 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-683-0404    Fax: 956-683-0450

News Archive

New hunt for intrinsic mechanism linked to schizophrenia

Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia. In particular, there was a search for chemicals that might be related to the hallucinogens phencyclidine (PCP) or lysergic acid diethylamide (LSD), which could explain the emergence of psychotic symptoms in schizophrenia.

New review outlines basic principles of dietary treatment

Thanks to screening of newborns and newly developed therapies, the population of patients with inherited metabolic disorders has expanded. As these patients age and enter adulthood, diet therapy will be the mainstay of treatment for their disorders.

Jackson Laboratory associate professor receives grant to study gene regulation at RNA level

Jackson Laboratory Associate Professor Jeffrey Chuang, Ph.D., has been awarded a two-year grant totaling $519,750 from the National Human Genome Research Institute for his studies of how RNA (molecules vital to protein formation in cells) interacts with proteins to change how genes are expressed.

FDA approves expansion of NeoVista's phase 3 study for wet AMD

NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States.

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

A new range of vitamins and food supplements developed to enhance the health of specific organs has been launched in the UK.

Read more Medical News

› Verified 4 days ago